Skip to Main content Skip to Navigation
Journal articles

CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features

Abstract : CARM1 and PRMT1 are 2 Protein Arginine Methyl Transferases (PRMT) dysregulated in cancer. CARM1 function is contradictory and depicted as facilitating proliferation or differentiation. PRMT1 is required for cell proliferation. CARM1 and PRMT1 cooperate for gene regulation. We report that CARM1 and PRMT1 are significantly overexpressed in 60 patients with Non-Small Cell Lung Carcinomas (NSCLC). CARM1 and PRMT1 correlated in healthy but not tumor tissue. Their levels of expression in tumor tissue were proportional to their levels of expression in the counterpart healthy tissue. Only CARM1 expression was found to be correlated with tumor differentiation and neither CARM1 nor PRMT1 expression was correlated with survival. Accordingly, CARM1 and PRMT1 are overexpressed in 2 NSCLC cell lines, A549 and H1299. Targeting PRMT1 with siRNA reduced proliferation, by decreasing cell growth and inhibiting soft agar colony formation, and promoted differentiation, by increasing the epithelial markers cytokeratin 7 and 8 and decreasing Neuromedin B receptor, which binds a mitogenic factor. siCARM1 yielded similar consequences but the conditions with siCARM1 reflected inhibition of both CARM1 and PRMT1. Together these results suggest that CARM1 and PRMT1 are involved in proliferation in lung cancer with no hierarchy of one protein over the other. The fact that CARM1 targeting suppresses PRMT1 in addition to CARM1 reinforces the functional importance of CARM1/PRMT1 interaction.
Document type :
Journal articles
Complete list of metadata

https://hal.univ-lorraine.fr/hal-01687383
Contributor : Ngere Ul <>
Submitted on : Thursday, January 18, 2018 - 2:19:03 PM
Last modification on : Tuesday, October 13, 2020 - 10:46:22 AM

Identifiers

Collections

Citation

Rania Elakoum, Guillaume Gauchotte, Abderrahim Oussalah, Marie-Pierre Wissler, Christelle Clement-Duchene, et al.. CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features. Biochimie, Elsevier, 2014, 97, pp.210 - 218. ⟨10.1016/j.biochi.2013.10.021⟩. ⟨hal-01687383⟩

Share

Metrics

Record views

127